NFKB1 and neoplasm: Inhibition of the NF-κB signaling pathway could significantly inhibit cytokines associated with tumor immune escape, including TGF-β, IL-10 and the member of the CC chemokine subfamily (CCL-22), thereby restoring the activity of depleted T lymphocyte.